222 related articles for article (PubMed ID: 29342352)
1. Chemically Defined Antibody- and Small Molecule-Drug Conjugates for in Vivo Tumor Targeting Applications: A Comparative Analysis.
Cazzamalli S; Dal Corso A; Widmayer F; Neri D
J Am Chem Soc; 2018 Feb; 140(5):1617-1621. PubMed ID: 29342352
[TBL] [Abstract][Full Text] [Related]
2. A Carbonic Anhydrase IX (CAIX)-Anchored Rhenium(I) Photosensitizer Evokes Pyroptosis for Enhanced Anti-Tumor Immunity.
Su X; Wang WJ; Cao Q; Zhang H; Liu B; Ling Y; Zhou X; Mao ZW
Angew Chem Int Ed Engl; 2022 Feb; 61(8):e202115800. PubMed ID: 34842317
[TBL] [Abstract][Full Text] [Related]
3. PEG Linker Length Strongly Affects Tumor Cell Killing by PEGylated Carbonic Anhydrase Inhibitors in Hypoxic Carcinomas Expressing Carbonic Anhydrase IX.
Mondal UK; Doroba K; Shabana AM; Adelberg R; Alam MR; Supuran CT; Ilies MA
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498779
[TBL] [Abstract][Full Text] [Related]
4. Sulfonamido carboranes as highly selective inhibitors of cancer-specific carbonic anhydrase IX.
Dvořanová J; Kugler M; Holub J; Šícha V; Das V; Nekvinda J; El Anwar S; Havránek M; Pospíšilová K; Fábry M; Král V; Medvedíková M; Matějková S; Lišková B; Gurská S; Džubák P; Brynda J; Hajdúch M; Grüner B; Řezáčová P
Eur J Med Chem; 2020 Aug; 200():112460. PubMed ID: 32505851
[TBL] [Abstract][Full Text] [Related]
5. Linker stability influences the anti-tumor activity of acetazolamide-drug conjugates for the therapy of renal cell carcinoma.
Cazzamalli S; Corso AD; Neri D
J Control Release; 2017 Jan; 246():39-45. PubMed ID: 27890855
[TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of specific carbonic anhydrase inhibitors effect on hypoxic cells using electrical impedance assays.
Stanica L; Gheorghiu M; Stan M; Polonschii C; David S; Bratu D; Dinischiotu A; Supuran CT; Gheorghiu E
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1079-1090. PubMed ID: 28783982
[TBL] [Abstract][Full Text] [Related]
7. Anti-breast cancer action of carbonic anhydrase IX inhibitor 4-[4-(4-Benzo[1,3]dioxol-5-ylmethyl-piperazin-1-yl)-benzylidene-hydrazinocarbonyl]-benzenesulfonamide (BSM-0004):
Mishra CB; Mongre RK; Prakash A; Jeon R; Supuran CT; Lee MS
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):954-963. PubMed ID: 33947294
[TBL] [Abstract][Full Text] [Related]
8. Development of a Small Molecule Tubulysin B Conjugate for Treatment of Carbonic Anhydrase IX Receptor Expressing Cancers.
Marks IS; Gardeen SS; Kurdziel SJ; Nicolaou ST; Woods JE; Kularatne SA; Low PS
Mol Pharm; 2018 Jun; 15(6):2289-2296. PubMed ID: 29715036
[TBL] [Abstract][Full Text] [Related]
9. Dual-pharmacophore DNA-encoded chemical libraries.
Scheuermann J; Neri D
Curr Opin Chem Biol; 2015 Jun; 26():99-103. PubMed ID: 25779969
[TBL] [Abstract][Full Text] [Related]
10. 1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions.
Coviello V; Marchi B; Sartini S; Quattrini L; Marini AM; Simorini F; Taliani S; Salerno S; Orlandi P; Fioravanti A; Desidero TD; Vullo D; Da Settimo F; Supuran CT; Bocci G; La Motta C
J Med Chem; 2016 Jul; 59(13):6547-52. PubMed ID: 27305384
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Therapeutic Activity of Non-Internalizing Small-Molecule-Drug Conjugates Targeting Carbonic Anhydrase IX in Combination with Targeted Interleukin-2.
Cazzamalli S; Ziffels B; Widmayer F; Murer P; Pellegrini G; Pretto F; Wulhfard S; Neri D
Clin Cancer Res; 2018 Aug; 24(15):3656-3667. PubMed ID: 29691298
[No Abstract] [Full Text] [Related]
12. Design, synthesis & biological evaluation of ferulic acid-based small molecule inhibitors against tumor-associated carbonic anhydrase IX.
Aneja B; Queen A; Khan P; Shamsi F; Hussain A; Hasan P; Rizvi MMA; Daniliuc CG; Alajmi MF; Mohsin M; Hassan MI; Abid M
Bioorg Med Chem; 2020 May; 28(9):115424. PubMed ID: 32209296
[TBL] [Abstract][Full Text] [Related]
13. Antibody-Based Delivery of Cytokine Payloads to Carbonic Anhydrase IX Leads to Cancer Cures in Immunocompetent Tumor-Bearing Mice.
Ziffels B; Stringhini M; Probst P; Fugmann T; Sturm T; Neri D
Mol Cancer Ther; 2019 Sep; 18(9):1544-1554. PubMed ID: 31213507
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological activity and multiscale molecular modeling studies of bis-coumarins as selective carbonic anhydrase IX and XII inhibitors with effective cytotoxicity against hepatocellular carcinoma.
Kurt BZ; Dag A; Doğan B; Durdagi S; Angeli A; Nocentini A; Supuran CT; Sonmez F
Bioorg Chem; 2019 Jun; 87():838-850. PubMed ID: 31003041
[TBL] [Abstract][Full Text] [Related]
15. Lansoprazole and carbonic anhydrase IX inhibitors sinergize against human melanoma cells.
Federici C; Lugini L; Marino ML; Carta F; Iessi E; Azzarito T; Supuran CT; Fais S
J Enzyme Inhib Med Chem; 2016; 31(sup1):119-125. PubMed ID: 27142956
[TBL] [Abstract][Full Text] [Related]
16. Targeting carbonic anhydrase IX with small organic ligands.
Wichert M; Krall N
Curr Opin Chem Biol; 2015 Jun; 26():48-54. PubMed ID: 25721398
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel pyridine-thiazolidinone derivatives as anticancer agents: Targeting human carbonic anhydrase IX.
Ansari MF; Idrees D; Hassan MI; Ahmad K; Avecilla F; Azam A
Eur J Med Chem; 2018 Jan; 144():544-556. PubMed ID: 29289880
[TBL] [Abstract][Full Text] [Related]
18. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform.
Ibrahim HS; Allam HA; Mahmoud WR; Bonardi A; Nocentini A; Gratteri P; Ibrahim ES; Abdel-Aziz HA; Supuran CT
Eur J Med Chem; 2018 May; 152():1-9. PubMed ID: 29684705
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of carbonic anhydrase-IX by sulphonamide derivatives induces pH and reactive oxygen species-mediated apoptosis in cervical cancer HeLa cells.
Koyuncu I; Gonel A; Kocyigit A; Temiz E; Durgun M; Supuran CT
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1137-1149. PubMed ID: 30001631
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the anticancer potential of a sulphonamide carbonic anhydrase IX inhibitor on cervical cancer cells.
Koyuncu I; Tülüce Y; Slahaddin Qadir H; Durgun M; Supuran CT
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):703-711. PubMed ID: 30810431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]